注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Pliant Therapeutics Inc是一家臨床階段的生物製藥公司。該公司專注於發現和開發治療纖維化及相關疾病的療法。它專注於通過抑制整合素介導的轉化生長因子β (TGF-B)激活治療纖維化。其主要候選產品PLN-74809是一種口服小分子、雙選擇性av?6和avB1抑製劑。該公司的第二個候選產品PLN-1474是一種小分子選擇性avB1抑製劑,用於治療與非酒精性脂肪性肝炎相關的肝纖維化。除了其臨床項目外,它還在開發其他基於整合素的臨床前項目。第一個臨床前項目是腫瘤學項目。它的第二個臨床前項目是正在開發針對一種未公開整合素受體的變構激動單克隆抗體,用於治療肌營養不良症,包括杜氏肌營養不良症。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Suzanne L. Bruhn | 58 | 2016 | Independent Director |
Bernard Coulie | 55 | 2016 | President, CEO & Director |
Gayle A. Crowell | 71 | 2019 | Independent Director |
Smital Shah | 46 | 2019 | Independent Director |
Dean Sheppard | - | 2015 | Scientific Founder & Member of Scientific Advisory Board |
Hal Chapman | - | 2015 | Scientific Founder & Member of Scientific Advisory Board |
Rik Derynck | - | 2015 | Scientific Founder & Member of Scientific Advisory Board |
Bill DeGrado | - | 2015 | Scientific Founder & Member of Scientific Advisory Board |
Hoyoung Huh | 54 | 2017 | Independent Chairman |
John T. Curnutte | 73 | 2017 | Independent Director |
Brian W. Metcalf | 78 | - | Member of Scientific Advisory Board |
Bill Greenlee | - | - | Member of Scientific Advisory Board |
Naftali Kaminski | - | - | Member of Scientific Advisory Board |
David R. Phillips | - | - | Member of Scientific Advisory Board |
Paul W. Noble | - | - | Member of Scientific Advisory Board |
Bertus Eksteen | - | - | Member of Scientific Advisory Board |
David E. I. Pyott | 71 | 2021 | Independent Director |
Katharine Knobil | 59 | 2022 | Independent Director |
Thomas A. McCourt | 67 | 2023 | Independent Director |
Darren S. Cline | 60 | 2023 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核